HRP921354A2 - Matrix with cells adherently bounded to it, and the process for the production of viruses/virus antigenes - Google Patents

Matrix with cells adherently bounded to it, and the process for the production of viruses/virus antigenes

Info

Publication number
HRP921354A2
HRP921354A2 HRP921354A HRP921354A2 HR P921354 A2 HRP921354 A2 HR P921354A2 HR P921354 A HRP921354 A HR P921354A HR P921354 A2 HRP921354 A2 HR P921354A2
Authority
HR
Croatia
Prior art keywords
virus
cells
bound
matrix
fsme
Prior art date
Application number
Other languages
English (en)
Inventor
Wolfgang Mundt
Noel Barrett
Friedrich Dorner
Johann Eibl
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of HRP921354A2 publication Critical patent/HRP921354A2/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2531/00Microcarriers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24111Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24151Methods of production or purification of viral material
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HRP921354 1989-12-22 1992-11-25 Matrix with cells adherently bounded to it, and the process for the production of viruses/virus antigenes HRP921354A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT2928/89A AT393356B (de) 1989-12-22 1989-12-22 Verfahren zur herstellung von fsme-virus-antigen
YU242390A YU242390A (sh) 1989-12-22 1990-12-21 Matrica s celicami, vezanimi nanjo adherentno, kot tudi postopek za proizvodnjo virusa/virusantigena

Publications (1)

Publication Number Publication Date
HRP921354A2 true HRP921354A2 (en) 1996-02-29

Family

ID=3542524

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP921354 HRP921354A2 (en) 1989-12-22 1992-11-25 Matrix with cells adherently bounded to it, and the process for the production of viruses/virus antigenes

Country Status (16)

Country Link
EP (1) EP0506714B1 (cs)
JP (1) JP2633391B2 (cs)
AT (2) AT393356B (cs)
CA (1) CA2071954C (cs)
CZ (1) CZ281804B6 (cs)
DE (1) DE59007659D1 (cs)
DK (1) DK0506714T3 (cs)
ES (1) ES2067916T3 (cs)
FI (1) FI98377C (cs)
HR (1) HRP921354A2 (cs)
HU (1) HU213886B (cs)
NO (1) NO310305B1 (cs)
RU (1) RU2082757C1 (cs)
SK (1) SK279236B6 (cs)
WO (1) WO1991009935A1 (cs)
YU (1) YU242390A (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2205015C (en) * 1994-11-10 2003-04-08 Otfried Kistner Method for producing biologicals in protein-free culture
NZ315357A (en) * 1995-08-01 1999-08-30 Pasteur Merieux Serums Vacc Method for industrially producing a japanese encephalitis vaccine, and resulting vaccine
FR2737412B1 (fr) * 1995-08-01 1997-10-24 Pasteur Merieux Serums Vacc Procede de production d'un vaccin contre le virus de l'encephalite japonaise et vaccin obtenu par ce procede
KR20010032699A (ko) 1998-10-05 2001-04-25 무따이 마사히꼬 일본 뇌염 바이러스 감염에 대한 불활성 백신을 위한증강된 면역원 및 그 제조방법
AT409379B (de) 1999-06-02 2002-07-25 Baxter Ag Medium zur protein- und serumfreien kultivierung von zellen
US6855535B2 (en) * 2001-12-10 2005-02-15 Baxter Healthcare S.A. Method of large scale production of Hepatitis A virus
US6951752B2 (en) 2001-12-10 2005-10-04 Bexter Healthcare S.A. Method for large scale production of virus antigen
JP2007068401A (ja) * 2003-08-07 2007-03-22 Chemo Sero Therapeut Res Inst 西ナイルウイルスワクチン
PL2235197T3 (pl) * 2007-12-27 2018-01-31 Baxalta GmbH Sposoby hodowli komórek

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT358167B (de) * 1978-12-22 1980-08-25 Immuno Ag Verfahren zur herstellung von fruehsommer- -meningoenzephalitis-virus (fsme-virus)- -vakzinen
SE445116B (sv) * 1979-09-12 1986-06-02 Pharmacia Fine Chemicals Ab Sett att odla celler pa mikroberare med fibronektinytskikt
NO161446C (no) * 1981-03-13 1989-08-16 Damon Biotech Inc Fremgangsmaate for dyrking av celler som er avhengige av forankring.
SE8103138L (sv) * 1981-05-19 1982-11-20 Pharmacia Fine Chemicals Ab Mikroberare for odling av forankringsberoende celler
CA1206900A (en) * 1981-12-21 1986-07-02 Raymond L. Downs Hollow glass shell microcarrier for growth of cell cultures, and method of shell manufacture
AT385203B (de) * 1985-04-26 1988-03-10 Immuno Ag Verfahren zur herstellung einer fruehsommermeningoenzephalitis-virus (fsme-virus)-vakzine
DD274336A3 (de) * 1985-10-03 1989-12-20 Npo Biolar Verfahren zur Gewinnung einer Mikroträgersubstanz für die Zellkultivierung

Also Published As

Publication number Publication date
FI98377B (fi) 1997-02-28
NO922422D0 (no) 1992-06-19
NO310305B1 (no) 2001-06-18
RU2082757C1 (ru) 1997-06-27
FI922851A0 (fi) 1992-06-18
CZ281804B6 (cs) 1997-02-12
CZ659090A3 (en) 1996-11-13
EP0506714B1 (de) 1994-11-02
JPH05502581A (ja) 1993-05-13
DK0506714T3 (da) 1995-04-18
WO1991009935A1 (de) 1991-07-11
DE59007659D1 (de) 1994-12-08
EP0506714A1 (de) 1992-10-07
NO922422L (no) 1992-08-17
SK659090A3 (en) 1998-08-05
JP2633391B2 (ja) 1997-07-23
FI98377C (fi) 1997-06-10
HU9202009D0 (en) 1992-10-28
FI922851A7 (fi) 1992-06-18
SK279236B6 (sk) 1998-08-05
CA2071954C (en) 1996-06-18
ES2067916T3 (es) 1995-04-01
ATA292889A (de) 1991-03-15
ATE113652T1 (de) 1994-11-15
YU242390A (sh) 1993-05-28
HU213886B (en) 1997-11-28
AT393356B (de) 1991-10-10
CA2071954A1 (en) 1991-06-23
HUT65410A (en) 1994-06-28

Similar Documents

Publication Publication Date Title
ATE482267T1 (de) Tierzellen und verfahren für die replikation von influenza viren
SE8000243L (sv) Typ ii-interferon och medel innehallande detsamma
ATE2014T1 (de) Lebendes, attenuiertes virus des hepatitis a beim menschen, verfahren zu seiner zuechtung in zellkultur in vitro und dieses virus enthaltende zusammensetzung.
BR8405600A (pt) Processo para estabelecer uma cultura de crescimento em um vaso,vaso selado,conjunto para preparar uma cultura de crescimento de microorganismos e processo para secar por congelamento microorganismos e nutriente e para estabelecer uma cultura de crescimento em um vaso
DE69626022D1 (de) Verfahren zur industriellen herstellung eines japanischen enkephalitis impfstoffes, und so erhaltener impfstoff
McLaren et al. THE MAMMALIAN CELL-VIRUS RELATIONSHIP: V. Susceptibility and Resistance of Cells in Vitro to Infection by Coxsackie A9 Virus
HRP921354A2 (en) Matrix with cells adherently bounded to it, and the process for the production of viruses/virus antigenes
NL300020I1 (nl) Produktie van virus-antigenen.
ES8104405A1 (es) Procedimiento para preparar una vacuna de virus de gripe
US4169761A (en) Process for the cultivation of viruses
Epstein et al. Adenosine triphosphatase activity at the surface of mature extracellular herpes virus
US4433052A (en) Process for producing interferon
KR930018034A (ko) 트레할로오스의 제조방법
AU6262786A (en) Growing aids virus in cell lines lacking human class ii histocompatability antigens
FR2261779A1 (en) Anti-rabies vaccine - obtd. from rabies virus grown on foetal calf kidney cells in a synthetic serum-free medium
FR2290219A1 (fr) Principe actif de vaccin antipyocyanique
CA2250714A1 (en) Animal cells and processes for the replication of influenza viruses
Mazurkova et al. Optimization of Reproduction Conditions of the Vaccine Cold-Adapted Recombinant Strains of Influenza Virus in Roller-Cultivated MDCK Cells
SU1109990A1 (ru) Способ выращивания вируса ящура
Lakhonina et al. Simplified methods for the isolation and preservation of axenic Lamblia cultures
JPS5588695A (en) Removal of methylguanidine
TH162A (th) กรรมวิธีสำหรับเตรียมวัคซีนป้องกันโรคกลัวน้ำ
NL7709998A (en) Foetal canine lung diploid cell line - for virus cultures esp. for rabies vaccine prodn.
UA21969A1 (uk) Спосіб виготовлеhhя іhактивоваhої культуральhої вакциhи проти хвороби ауескі
KR870009018A (ko) 단순 포진에 대한 왁진

Legal Events

Date Code Title Description
A1OB Publication of a patent application
OBST Application withdrawn